Form 8-K - Current report:
SEC Accession No. 0001104659-24-128519
Filing Date
2024-12-13
Accepted
2024-12-13 17:18:10
Documents
14
Period of Report
2024-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431031d1_8k.htm   iXBRL 8-K 27314
2 EXHIBIT 10.1 tm2431031d1_ex10-1.htm EX-10.1 79995
  Complete submission text file 0001104659-24-128519.txt   304162

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA akya-20241211.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE akya-20241211_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akya-20241211_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2431031d1_8k_htm.xml XML 3808
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

EIN.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 241549403
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)